Skip Navigation

Post-Doctoral Training Grant In Cancer Survivorship

External Advisory Committee

The Post-Doctoral Training Program in Cancer Survivorship has an External Advisory Committee made up of four senior scientists who have significant expertise in leading training grants and in cancer survivorship.  Members of this Committee have agreed to consider sponsoring trainees at their respective institutions for short periods of time to provide additional collaborative opportunities.  Advisory members include:

Robert M. Chamberlain, PhD, is the Ashbel Smith Professor of Epidemiology and Deputy Chair of the Department of Epidemiology at the University of Texas, M.D. Anderson Cancer Center in Houston.  Dr. Chamberlain developed the largest NCI-funded cancer prevention training program in the country which has been continuously funded for 15 years.  He also serves as PI on an NCI-funded 3-month traineeship for 18 graduate and medical students that is in its 15th year of funding. These programs are designed to focus the careers of new cancer prevention scientists in fields ranging from tumor biology to behavioral science.  He has assisted more than 20 former postdoctoral fellows make successful applications for NCI K07, K22, or ACS career development grants.

Wendy Demark-Wahnefried, PhD, RD, LDN, is the Associate Director for Cancer Prevention and Control for the University of Alabama at Birmingham Comprehensive Cancer Center and Professor of Nutrition Sciences. She is internationally recognized for her work in nutrition and exercise.  Her research has focused on the assessment of risk factors for prostate cancer, determining causes and prevention of weight gain during treatment for breast cancer, and delivering dietary interventions aimed at either primary or secondary prevention. In 2003, Dr. Demark-Wahnefried was named a Susan G. Komen Professor of Survivorship for her work in energy balance and breast cancer.  She is a past recipient of the National Cancer Institute's Preventive Oncology Academic Award and has served as an external reviewer for the National Academy of Sciences/Institute of Medicine Fulfilling the Promise for Cancer Prevention and Early Detection program, the American Cancer Society’s Nutrition and Physical Activity Cancer Survivor Workgroup, and is a committee member for the Institute of Medicine’s National Cancer Survivorship Care Plan. 

Mark B. Dignan, PhD, MPH, is a Professor in the Department of Internal Medicine at the University of Kentucky and the Director of the CDC-funded University of Kentucky Prevention Research Center (UKPRC).  His research has focused on cancer prevention and control with an emphasis on cancer health disparities. His work has included projects that developed and evaluated mass media programs, lay health advisor and navigator interventions for patients and the public, and health care provider programs designed to increase screening and adherence to follow-up recommendations among medically underserved rural and minority populations. Dr. Dignan has directed two large research projects.  The NCI funded “Appalachia Community Cancer Network” (1 U01 CA114622) is a collaborative project using a multidisciplinary team of investigators from academic institutions and communities in Appalachian regions of Kentucky, West Virginia and Ohio with a goal of addressing cancer health disparities in seven areas of Appalachia.  “Patient Navigation for Cervical Cancer in Appalachia” (R01 CA120606) focuses on using lay health workers in local health departments to increase cervical cancer screening in rural Kentucky. 

Patricia A. Ganz, MD, is a Professor of Health Services and Medicine at the UCLA School of Public Health Department of Health Services. She is a preeminent leader in the field of cancer survivorship and a leader in the integration of quality-of-life assessment in clinical trials. She has conducted federally funded research for over two decades and has led several large clinical intervention trials in breast cancer. Her current research focuses on the late effects of cancer treatment. Other collaborative work is examining the quality of care for cancer patients. Dr. Ganz is also currently the Director of the Division of Cancer Prevention and Control Research of the Jonsson Comprehensive Cancer Center at UCLA and leads a large research group.

Dr. Ganz’s “Cognitive Functioning after Breast Cancer Treatment” (NCI) examines the potential mechanisms by which endocrine therapy affects cerebral functioning in a longitudinal, observational cohort study of 260 breast cancer patients enrolled at the end of primary treatment when endocrine therapy is initiated and one year later. PET scanning is employed in a subset of participants. In addition, she has a number of other current and completed projects funded through the National Cancer Institute, the Breast Cancer Treatment Foundation, and the American Cancer Society.

Dr. Ganz is Associate Editor of  the Journal of the National Cancer Institute and is a member of the editorial group for the Cochrane Breast Cancer Group. She is also a member of the National Cancer Institute Board of Scientific Advisors. In 1999 she was named an American Cancer Society Clinical Research Professor. She is a founding member of the National Coalition for Cancer Survivorship (NCCS), and was previously awarded the Susan G. Komen Professor of Survivorship.

Last Updated: 06-28-2016
Wake Forest Baptist Ranked among Nation’s ‘Best Hospitals’  25 Years in a Row by U.S. News & World ReportComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsNursing Magnet StatusJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.